Markel Group Inc. Purchases 6,250 Shares of HCA Healthcare, Inc. $HCA

Markel Group Inc. boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 75,213 shares of the company’s stock after purchasing an additional 6,250 shares during the quarter. Markel Group Inc.’s holdings in HCA Healthcare were worth $32,056,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $1,021,000. NewEdge Advisors LLC grew its position in HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its stake in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the last quarter. Perigon Wealth Management LLC lifted its holdings in HCA Healthcare by 3.4% during the second quarter. Perigon Wealth Management LLC now owns 1,858 shares of the company’s stock worth $712,000 after acquiring an additional 61 shares during the period. Finally, Dakota Wealth Management raised its stake in shares of HCA Healthcare by 8.0% during the 2nd quarter. Dakota Wealth Management now owns 690 shares of the company’s stock worth $264,000 after purchasing an additional 51 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Up 0.5%

NYSE HCA opened at $473.08 on Tuesday. The stock’s 50-day simple moving average is $480.29 and its two-hundred day simple moving average is $434.98. The company has a market capitalization of $107.95 billion, a price-to-earnings ratio of 18.29, a PEG ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. During the same period last year, the business earned $4.90 earnings per share. The business’s quarterly revenue was up 9.6% on a year-over-year basis. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Sanford C. Bernstein reaffirmed a “market perform” rating and issued a $503.00 price target on shares of HCA Healthcare in a report on Tuesday, January 6th. Truist Financial increased their target price on shares of HCA Healthcare from $495.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, January 5th. Morgan Stanley downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price on the stock. in a research report on Monday, December 15th. Mizuho lifted their target price on HCA Healthcare from $505.00 to $520.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Finally, Zacks Research downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $488.75.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.